Disintegrin-like domain of glycoprotein B regulates Kaposi's sarcoma-associated herpesvirus infection of cells

被引:21
|
作者
Walker, Lia R. [1 ]
Hussein, Hosni A. M. [1 ]
Akula, Shaw M. [1 ]
机构
[1] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27834 USA
来源
关键词
CELLULAR RECEPTOR; TENASCIN-C; HUMAN-HERPESVIRUS-8; ENTRY; RAF; ALPHA-3-BETA-1; MOTIF; VEGF;
D O I
10.1099/vir.0.066829-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Kaposi's sarcoma-associated herpesvirus (KSHV) glycoprotein B (gB) is a lytic structural protein expressed on the envelope of mature virions and on the membrane of cells supporting lytic infection. In addition to this viral glycoprotein's interaction with integrins via its RGD (Arg-Gly-Asp) motif, KSHV gB possesses a disintegrin-like domain (DLD), which binds integrins as well. Prior to this study, there has been minimal research involving the less common integrin-binding motif, DLD, of gB as it pertains to herpesvirus infection. By using phage display peptide library screening and molecular biology techniques, the DLD of KSHV gB was shown to interact specifically with non-RGD binding alpha 9 beta 1 integrins. Similarly, monitoring wild-type infection confirmed alpha 9 beta 1 :DLD interactions to be critical to successful KSHV infection of human foreskin fibroblast (HFF) cells and human dermal microvascular endothelial cells (HMVEC-d) compared with 293 cells. To further demonstrate the importance of the DLD of gB in KSHV infection, two recombinant virus constructs were generated using a bacterial artificial chromosome (BAG) system harbouring the KSHV genome (BAC36): BAC36AD-KSHV (lacking a functionally intact DLD of gB and containing an introduced tetracycline cassette) and BAC36.T-KSHV (containing an intact DLD sequence and an introduced tetracycline cassette). Accordingly, BAC36AD-KSHV presented significantly lower infection rates in HFF and HMVEC-d cells compared with the comparable infection rates achieved by wild-type BAC36-KSHV and BAC36.T-KSHV. Thus, the present report has delineated a critical role for the DLD of gB in KSHV infection, which may lead to a broader knowledge regarding the sophisticated mechanisms utilized by virus-encoded structural proteins in KSHV entry and infection.
引用
收藏
页码:1770 / 1782
页数:13
相关论文
共 50 条
  • [41] RNAs in the virion of Kaposi's sarcoma-associated herpesvirus
    Bechtel, J
    Grundhoff, A
    Ganem, D
    JOURNAL OF VIROLOGY, 2005, 79 (16) : 10138 - 10146
  • [42] Kaposi's sarcoma-associated herpesvirus and extracellular vesicles
    Barrett, Lindsey
    Dai, Lu
    Wang, Shanzhi
    Qin, Zhiqiang
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (06) : 3294 - 3299
  • [43] The molecular pathology of Kaposi's sarcoma-associated herpesvirus
    Jenner, RG
    Boshoff, C
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2002, 1602 (01): : 1 - 22
  • [44] Molecular biology of Kaposi's sarcoma-associated herpesvirus
    Cotter, MA
    Robertson, ES
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2002, 7 : D358 - D375
  • [45] Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus
    Calvez, V
    EUROCANCER 98, 1998, : 189 - 193
  • [46] The role of Kaposi's sarcoma-associated herpesvirus in oncogenesis
    Fujimuro, M
    SEIKAGAKU, 2004, 76 (02): : 140 - 143
  • [47] Epigenetic diversity of Kaposi's sarcoma-associated herpesvirus
    Darst, Russell P.
    Haecker, Irina
    Pardo, Carolina E.
    Renne, Rolf
    Kladde, Michael P.
    NUCLEIC ACIDS RESEARCH, 2013, 41 (05) : 2993 - 3009
  • [48] Functions of Kaposi's sarcoma-associated herpesvirus microRNAs
    Ziegelbauer, Joseph M.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2011, 1809 (11-12): : 623 - 630
  • [49] Immune evasion by Kaposi's sarcoma-associated herpesvirus
    Laurent Coscoy
    Nature Reviews Immunology, 2007, 7 : 391 - 401
  • [50] Immune evasion by Kaposi's sarcoma-associated herpesvirus
    Lee, Hye-Ra
    Lee, Stacy
    Chaudhary, Preet M.
    Gill, Parkash
    Jung, Jae U.
    FUTURE MICROBIOLOGY, 2010, 5 (09) : 1349 - 1365